Nerve Repair and Regeneration Market Forecast: Rising R&D Investments and Research Expenditures to Drive Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Nerve Repair and Regeneration Market by Products (Neuromodulation Devices (Deep Brain Stimulation, Vagus Nerve Stimulation), Biomaterials (Nerve Conduits, Nerve Envelopes), Application (Neurorrhaphy, Nerve Graft, Cell Therapy strains) – global forecast to 2027” the report has been added to from ResearchAndMarkets.com offer.

The global nerve repair and regeneration market is expected to reach USD 11.6 billion by 2027, from USD 6.5 billion in 2022, growing at a CAGR of 12.1%. The growth of this market is driven by increasing spending on neurological disorder research by the government, increasing R&D investments by market players in neuromodulation and neurostimulation devices, and biomaterials. Additionally, the expanding geriatric population is drying up the growth of the market by increasing the demand for nerve repair and regeneration products.

The biomaterials segment as a segment is expected to grow at the fastest growth rate over the forecast period.

On the basis of product type, the nerve repair and regeneration market is segmented into neurostimulation and neuromodulation devices and biomaterials. The biomaterials segment is expected to register the highest CAGR, driven by research investments and R&D expenditures by government and market players.

The segment of internal neurostimulation and neuromodulation represents the largest share during the analysis period.

On the basis of neurostimulation and neuromodulation application, nerve repair and regeneration market is segmented, neurostimulation and neuromodulation devices market is segmented into internal neurostimulation and neuromodulation applications and external neurostimulation and neuromodulation. The internal neurostimulation neuromodulation segment holds the largest share during the forecast period owing to the increase in the cases of nerve damage and high incidence of neurological disorders.

The Asia-Pacific region is estimated to register the highest CAGR during the study period. North America is expected to dominate the market share

In this report, the nerve repair and regeneration market is segmented into four major regional segments, namely North America, Europe, Asia-Pacific and Rest of the World (Middle East and Africa and Latin America). In 2021, North America held the largest market share owing to the presence of major players and advanced healthcare infrastructure.

The Asia-Pacific market is expected to grow at the highest growth rate over the forecast period owing to massive population, increasing economic growth, improved healthcare infrastructure, and healthcare expenditure. health, high respect for neurological diseases and growing demand.

Main topics covered:

1. Introduction

2 Research methodology

3 Executive summary

4 premium previews

4.1 Nerve Repair and Regeneration Market Overview

4.2 Nerve Repair and Regeneration Market, by Product and Country (2021)

4.3 Nerve Repair and Regeneration Market, by Region (2022 Vs 2027)

4.4 Nerve Repair and Regeneration Market: Geographic Growth Opportunities

5 Market Overview

5.1 Presentation

5.2 Market Dynamics

Figure 21 Nerve Repair and Regeneration Market: Drivers, Restraints, Opportunities and Challenges

5.2.1 Drivers

5.2.1.1 High incidence of nerve damage

5.2.1.2 Growing focus on neuromodulation and neurostimulation technologies

5.2.1.3 Increase in the geriatric population and subsequent increase in the prevalence of neurological disorders

5.2.1.4 Growing government support for research on neurological disorders

Figure 22 Nih (Us) Research Funding

5.2.2 Opportunities

5.2.2.1 Emerging markets

5.2.2.2 Advances in Stem Cell Therapy in Nerve Repair and Regeneration

5.2.2.3 Growing research projects in neurology

5.2.3 Challenges

5.2.3.1 Donor site morbidity

5.2.3.2 Difficulties treating large nerve lacunae

5.2.3.3 Rigorous regulatory frameworks and time-consuming approval processes

5.2.3.4 Increased preference for drug therapies over nerve repair and regeneration products

5.2.3.5 Shortage of trained professionals

5.2.3.6 Product recalls

Table 6 Major Product Recalls

5.3 Impact of COVID-19 on the Nerve Repair and Regeneration Market

5.4 Price Analysis

6 Nerve Repair and Regeneration Market, By Product

6.1 Presentation

6.2 Neurostimulation and neuromodulation devices

6.3 Biomaterials

7 Nerve Repair and Regeneration Market, by Application

7.1 Presentation

7.2 Neurostimulation & Neuromodulation

7.3 Nerve repair and regeneration biomaterials

8 Nerve Repair and Regeneration Market, by Region

9 Competitive landscape

Companies cited

  • Abbott Laboratories

  • Alafair Biosciences, Inc.

  • Aleva Neurotherapeutics SA

  • Axogen Society.

  • Baxter

  • United States

  • Boston Scientific Society

  • Checkpoint Surgical Inc.

  • Collagen Matrix Inc

  • Electrocore, Inc.

  • Medical Gimer

  • Integra Lifesciences

  • Kerimedical

  • Livanova plc

  • Medtronic, plc.

  • Neuronetics Inc.

  • Neuropace Inc.

  • Neurosigma, Inc.

  • Nevro Corp.

  • polyganic

  • Renishaw plc.

  • Soterix Medical Inc.

  • Synapse Biomedical Inc

  • Tvns Technologies Gmbh

For more information about this report visit https://www.researchandmarkets.com/r/it8kbk